insights_auto
Why is ARX up 3.03%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
AU$0.51
arrow_upward
+3.03%(+0.015) 1D
ኖቬም 12, 4:10:12 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
AU$0.50
High
AU$0.51
Low
AU$0.49
Mkt. cap
174.68 ሚ
Avg. vol.
278.05 ሺ
Volume
76.08 ሺ
P/E ratio
49.04
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Open
AU$0.50
High
AU$0.51
Low
AU$0.49
Mkt. cap
174.68 ሚ
Avg. vol.
278.05 ሺ
Volume
76.08 ሺ
P/E ratio
49.04
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
Investing.com
·
ከ7 ደቂቃዎች በፊት
Agora CEO Zhao Bin acquires $116,831 in nasdaq:api ads
BigGo Finance
·
ከ25 ደቂቃዎች በፊት
Micron and Sandisk Ride an AI Memory Crunch to the Top of the S&P 500
Bloomberg.com
·
ከ14 ሰዓቶች በፊት
Nasdaq 100 Advances 3% as Easing AI Anxiety Draws Dip Buyers In
markets.businessinsider.com
·
ከ14 ሰዓቶች በፊት
NextNRG Announces Nasdaq Delisting Determination; Trading to Be Suspended at Market Open on November 12, 2026
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd